Atlas Trials

Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure

Clinical trial NCT00894868 · COMPLETED

Trial details

NCT number
NCT00894868
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Congestive Heart FailureType II Diabetes Mellitus
Start date
2009-05-01
Primary completion
2012-08-01
Enrollment
798

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.